In the US, REMODULIN (treprostinil systemic) is a member of the drug class agents for pulmonary hypertension and is used to treat Pulmonary Hypertension.
Ingredient matches for REMODULIN
Treprostinil is reported as an ingredient of REMODULIN in the following countries:
Treprostinil monosodium (a derivative of Treprostinil) is reported as an ingredient of REMODULIN in the following countries:
- Croatia (Hrvatska)
- Czech Republic
- United States
← International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.